These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29274340)

  • 1. Four unreported types of glycans containing mannose-6-phosphate are heterogeneously attached at three sites (including newly found Asn 233) to recombinant human acid alpha-glucosidase that is the only approved treatment for Pompe disease.
    Park H; Kim J; Lee YK; Kim W; You SK; Do J; Jang Y; Oh DB; Il Kim J; Kim HH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2418-2424. PubMed ID: 29274340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seventeen O-acetylated N-glycans and six O-acetylation sites of Myozyme identified using liquid chromatography-tandem mass spectrometry.
    Park H; You S; Kim J; Kim W; Do J; Jang Y; Kim D; Lee J; Ha J; Oh DB; Kim JI; Kim HH
    J Pharm Biomed Anal; 2019 May; 169():188-195. PubMed ID: 30877930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice.
    Zhu Y; Li X; McVie-Wylie A; Jiang C; Thurberg BL; Raben N; Mattaliano RJ; Cheng SH
    Biochem J; 2005 Aug; 389(Pt 3):619-28. PubMed ID: 15839836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.
    Basile I; Da Silva A; El Cheikh K; Godefroy A; Daurat M; Harmois A; Perez M; Caillaud C; Charbonné HV; Pau B; Gary-Bobo M; Morère A; Garcia M; Maynadier M
    J Control Release; 2018 Jan; 269():15-23. PubMed ID: 29108866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of recombinant human acid α-glucosidase with high-mannose glycans in gnt1 rice for the treatment of Pompe disease.
    Jung JW; Huy NX; Kim HB; Kim NS; Van Giap D; Yang MS
    J Biotechnol; 2017 May; 249():42-50. PubMed ID: 28363873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.
    Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B
    J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease.
    Zhu Y; Jiang JL; Gumlaw NK; Zhang J; Bercury SD; Ziegler RJ; Lee K; Kudo M; Canfield WM; Edmunds T; Jiang C; Mattaliano RJ; Cheng SH
    Mol Ther; 2009 Jun; 17(6):954-63. PubMed ID: 19277015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.
    El Cheikh K; Basile I; Da Silva A; Bernon C; Cérutti P; Salgues F; Perez M; Maynadier M; Gary-Bobo M; Caillaud C; Cérutti M; Garcia M; Morère A
    Angew Chem Int Ed Engl; 2016 Nov; 55(47):14774-14777. PubMed ID: 27774736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal Targeting Enhancement by Conjugation of Glycopeptides Containing Mannose-6-phosphate Glycans Derived from Glyco-engineered Yeast.
    Kang JY; Shin KK; Kim HH; Min JK; Ji ES; Kim JY; Kwon O; Oh DB
    Sci Rep; 2018 Jun; 8(1):8730. PubMed ID: 29880804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
    Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
    Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice.
    Anding A; Kinton S; Baranowski K; Brezzani A; De Busser H; Dufault MR; Finn P; Keefe K; Tetrault T; Li Y; Qiu W; Raes K; Vitse O; Zhang M; Ziegler R; Sardi SP; Hunter B; George K
    J Pharmacol Exp Ther; 2023 Nov; 387(2):188-203. PubMed ID: 37679046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease.
    McVie-Wylie AJ; Lee KL; Qiu H; Jin X; Do H; Gotschall R; Thurberg BL; Rogers C; Raben N; O'Callaghan M; Canfield W; Andrews L; McPherson JM; Mattaliano RJ
    Mol Genet Metab; 2008 Aug; 94(4):448-455. PubMed ID: 18538603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis of N-linked glycans carrying both mannose-6-phosphate and GlcNAc-mannose-6-phosphate motifs.
    Liu Y; Chen G
    J Org Chem; 2011 Nov; 76(21):8682-9. PubMed ID: 21955083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoenzymatic glycan-selective remodeling of a therapeutic lysosomal enzyme with high-affinity M6P-glycan ligands. Enzyme substrate specificity is the name of the game.
    Zhang X; Liu H; Meena N; Li C; Zong G; Raben N; Puertollano R; Wang LX
    Chem Sci; 2021 Sep; 12(37):12451-12462. PubMed ID: 34603676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.
    Faid V; Evjen G; Tollersrud OK; Michalski JC; Morelle W
    Glycobiology; 2006 May; 16(5):440-61. PubMed ID: 16449350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of mannose 6-phosphate-containing oligosaccharides to acid alpha-glucosidase improves the clearance of glycogen in pompe mice.
    Zhu Y; Li X; Kyazike J; Zhou Q; Thurberg BL; Raben N; Mattaliano RJ; Cheng SH
    J Biol Chem; 2004 Nov; 279(48):50336-41. PubMed ID: 15383547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Neoglycan conjugation to human acid α-glucosidase.
    Zhou Q; Stefano JE; Harrahy J; Finn P; Avila L; Kyazike J; Wei R; Van Patten SM; Gotschall R; Zheng X; Zhu Y; Edmunds T; Pan CQ
    Bioconjug Chem; 2011 Apr; 22(4):741-51. PubMed ID: 21417264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase.
    Selvan N; Mehta N; Venkateswaran S; Brignol N; Graziano M; Sheikh MO; McAnany Y; Hung F; Madrid M; Krampetz R; Siano N; Mehta A; Brudvig J; Gotschall R; Weimer JM; Do HV
    J Biol Chem; 2021; 296():100769. PubMed ID: 33971197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of plant core-fucosylated N-glycans of acid alpha-glucosidases produced in transgenic rice cell suspension cultures treated with eight different conditions.
    Kim J; Do J; Choi HY; Kim SD; Park H; You S; Kim W; Jang Y; Kim D; Lee J; Ha J; Ji M; Kim DI; Kim HH
    Enzyme Microb Technol; 2020 Mar; 134():109482. PubMed ID: 32044029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease.
    Peng J; Dalton J; Butt M; Tracy K; Kennedy D; Haroldsen P; Cahayag R; Zoog S; O'Neill CA; Tsuruda LS
    J Pharmacol Exp Ther; 2017 Feb; 360(2):313-323. PubMed ID: 27856936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.